Join
Live feed
·
NEWSReleasevia Quantisnow
eXoZymes Inc. logo

eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast

ByQuantisnow·Wall Street's wire, on your screen.
EXOZ· eXoZymes Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EXOZ (eXoZymes Inc.) and more on Quantisnow.